ArticleAbdominal radiology (New York)2026
The added value of intratumoral and peritumoral radiomic scores based on iodine density map for preoperative prediction of lymphovascular invasion in patients with gastric adenocarcinoma: a two-center study.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo evaluate the added value of intratumoral and peritumoral radiomic scores (RS) of iodine density (IoD) map in the preoperative prediction of lymphovascular invasion (LVI) in gastric adenocarcinoma.
methodsA total of 226 patients, divided into groups with and without LVI, were randomly assigned to a training set (n = 137), an internal validation set (n = 59), and an external validation set (n = 30) that was recruited from two centers. Clinical characteristics and tumor spectral computed tomography (CT) parameters were collected and measured. Radiomic features were extracted from the IoD map within the intratumoral and peritumoral 1 mm, 3 mm, and 5 mm regions. Logistic regression was used to construct RS and to identify independent risk factors for LVI. The performance of each model was evaluated through receiver operating characteristic (ROC) curve analysis.
resultsA clinical-spectral model incorporating tumor CT-T stage, Borrmann classification, cell differentiation grade, and effective atomic number (Z-Eff) as risk factors achieved an area under the curve (AUC) of 0.841 in the training set. After the addition of intratumoral and peritumoral 5 mm RS as a risk factor to the clinical-spectral model, a nomogram was constructed, yielding a greater AUC of 0.925. The nomogram model achieved AUC of 0.872 and 0.947 in the internal and external validation sets, respectively, demonstrating superior performance compared to the clinical-spectral model.
conclusionIntratumoral and peritumoral 5 mm RS based on iodine density map can provide additional value in enhancing the preoperative prediction of LVI in patients with gastric adenocarcinoma.
Indexed as
Identifiers
41251735What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.